首页 > 最新文献

The Ulster medical journal最新文献

英文 中文
Curiositas - Psychiatric Puzzles. Curiositas -精神病学难题。
Pub Date : 2025-09-01 Epub Date: 2025-09-30
{"title":"Curiositas - Psychiatric Puzzles.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 2","pages":"107-108"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mutation characterisation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in people with cystic fibrosis in Northern Ireland. 北爱尔兰囊性纤维化患者囊性纤维化跨膜传导调节(CFTR)基因的突变特征
Pub Date : 2025-09-01 Epub Date: 2025-09-30
Philippa J Blevings, John E Moore, John McCaughan, Alastair Reid, Jacqueline C Rendall, Beverley C Millar
<p><strong>Background: </strong>Cystic fibrosis (CF), which is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene is the most common life-limiting autosomal recessive genetic disease in Northern Ireland. Currently, Northern Ireland has approximately 520 people with CF (PwCF) (312 adults, 208 children) and a defective gene carrier rate of 1 in 22 persons, with approximately 86,507 carriers within the general population. Advances in DNA sequencing technology has allowed for better genetic characterisation of CFTR mutations. The aim of this project was to (i) examine current CFTR mutation frequency and type in paediatric and adult CF populations in Northern Ireland, (ii) examine CFTR mutational trends in relation to CF patients' age groups, (iii) compare Northern Ireland CFTR most common allele frequencies with those documented globally and (iv) establish a reference/baseline of CFTR mutation information prior to the effect of CFTR modulator therapy.</p><p><strong>Methods: </strong>Anonymised data comprising of birth year, sex, and known alleles of adult and paediatric individuals (n=520) from the Northern Ireland CF population was examined. Alleles were recorded according to legacy, protein and cDNA name and organised by mutation class and type, in accordance with CFTR2 database nomenclature. Individual known alleles frequencies from the complete Northern Ireland CF population (n=1005) were calculated and compared with the CFTR2 database, globally with CFTR data obtained from CF national registries.</p><p><strong>Results: </strong>Within the Northern Ireland CF population, there were 61 different CFTR mutational variants identified in a population of 1005 alleles. In descending occurrence, the most common was F508del with 626 alleles (62.3%), followed by R117H (8.9%), G551D (5.0%), G542X (3.3%), R560T (2.8%) and P67L (2.2%). The remaining alleles were present at a frequency of <2.0%. The six most frequently detected CFTR mutations accounted for 84.4% of all alleles. Over approximately two and a half decades (1996-2021), 23 CFTR mutations remain shared. Six alleles, which were described in the 1996 CFTR analysis, were absent from the 2021 data, whilst there were additional descriptions of 39 allelic mutations, which occurred in the 2021 analysis, but which were not described in the 1996 analysis.</p><p><strong>Conclusion: </strong>Characterisation of CFTR mutation alleles from people with cystic fibrosis provides essential information to help predict disease severity and effect of targeted CFTR modulator therapy. These 2021 data provide a valuable genetic update from the 1996 data and a reference point on the status of the Northern Ireland CFTR mutation types and frequencies. CFTR modulator therapy has the potential to indirectly alter the current <i>status quo</i> and distribution of CFTR mutation types amongst children of PwCF, due to improved clinical status and fecundity. Revisiting this in a decade from n
背景:囊性纤维化(CF)是由囊性纤维化跨膜传导调节基因(CFTR)突变引起的,是北爱尔兰最常见的限制生命的常染色体隐性遗传病。目前,北爱尔兰约有520名CF (PwCF)患者(312名成人,208名儿童),每22人中就有1人携带有缺陷基因,总人口中约有86,507人携带有缺陷基因。DNA测序技术的进步使CFTR突变的遗传特征得到了更好的描述。该项目的目的是(i)检查目前北爱尔兰儿童和成人CF人群中CFTR突变的频率和类型,(ii)检查CFTR突变趋势与CF患者年龄组的关系,(iii)比较北爱尔兰CFTR最常见的等位基因频率与全球记录的等位基因频率,(iv)在CFTR调节剂治疗效果之前建立CFTR突变信息的参考/基线。方法:对来自北爱尔兰CF人群的成人和儿科个体(n=520)的出生年份、性别和已知等位基因的匿名数据进行了检查。根据遗传、蛋白质和cDNA名称记录等位基因,按照CFTR2数据库命名法,按突变类别和类型组织。计算来自完整的北爱尔兰CF人群(n=1005)的单个已知等位基因频率,并与CFTR2数据库进行比较,全球CFTR数据来自CF国家登记处。结果:在北爱尔兰CF群体中,在1005个等位基因群体中鉴定出61种不同的CFTR突变变体。在降序分布中,F508del最多,共有626个等位基因(62.3%),其次是R117H(8.9%)、G551D(5.0%)、G542X(3.3%)、R560T(2.8%)和P67L(2.2%)。结论:囊性纤维化患者CFTR突变等位基因的特征为帮助预测疾病严重程度和靶向CFTR调节剂治疗的效果提供了重要信息。这些2021年的数据提供了1996年数据的宝贵遗传更新,并提供了关于北爱尔兰CFTR突变类型和频率状况的参考点。由于改善了临床状况和生育能力,CFTR调节剂治疗有可能间接改变PwCF儿童中CFTR突变类型的现状和分布。从现在开始的十年中重新审视这一点将允许估计CFTR调节剂治疗对CFTR突变进化的间接影响。
{"title":"Mutation characterisation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in people with cystic fibrosis in Northern Ireland.","authors":"Philippa J Blevings, John E Moore, John McCaughan, Alastair Reid, Jacqueline C Rendall, Beverley C Millar","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Cystic fibrosis (CF), which is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene is the most common life-limiting autosomal recessive genetic disease in Northern Ireland. Currently, Northern Ireland has approximately 520 people with CF (PwCF) (312 adults, 208 children) and a defective gene carrier rate of 1 in 22 persons, with approximately 86,507 carriers within the general population. Advances in DNA sequencing technology has allowed for better genetic characterisation of CFTR mutations. The aim of this project was to (i) examine current CFTR mutation frequency and type in paediatric and adult CF populations in Northern Ireland, (ii) examine CFTR mutational trends in relation to CF patients' age groups, (iii) compare Northern Ireland CFTR most common allele frequencies with those documented globally and (iv) establish a reference/baseline of CFTR mutation information prior to the effect of CFTR modulator therapy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Anonymised data comprising of birth year, sex, and known alleles of adult and paediatric individuals (n=520) from the Northern Ireland CF population was examined. Alleles were recorded according to legacy, protein and cDNA name and organised by mutation class and type, in accordance with CFTR2 database nomenclature. Individual known alleles frequencies from the complete Northern Ireland CF population (n=1005) were calculated and compared with the CFTR2 database, globally with CFTR data obtained from CF national registries.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Within the Northern Ireland CF population, there were 61 different CFTR mutational variants identified in a population of 1005 alleles. In descending occurrence, the most common was F508del with 626 alleles (62.3%), followed by R117H (8.9%), G551D (5.0%), G542X (3.3%), R560T (2.8%) and P67L (2.2%). The remaining alleles were present at a frequency of &lt;2.0%. The six most frequently detected CFTR mutations accounted for 84.4% of all alleles. Over approximately two and a half decades (1996-2021), 23 CFTR mutations remain shared. Six alleles, which were described in the 1996 CFTR analysis, were absent from the 2021 data, whilst there were additional descriptions of 39 allelic mutations, which occurred in the 2021 analysis, but which were not described in the 1996 analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Characterisation of CFTR mutation alleles from people with cystic fibrosis provides essential information to help predict disease severity and effect of targeted CFTR modulator therapy. These 2021 data provide a valuable genetic update from the 1996 data and a reference point on the status of the Northern Ireland CFTR mutation types and frequencies. CFTR modulator therapy has the potential to indirectly alter the current &lt;i&gt;status quo&lt;/i&gt; and distribution of CFTR mutation types amongst children of PwCF, due to improved clinical status and fecundity. Revisiting this in a decade from n","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 2","pages":"64-76"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hugh Percy, 10th Duke of Northumberland: Chairmanship of the Agricultural and Medical Research Councils. 休·珀西,第十代诺森伯兰郡公爵:农业和医学研究委员会主席。
Pub Date : 2025-09-01 Epub Date: 2025-09-30
John Hedley-Whyte, Debra R Milamed
{"title":"Hugh Percy, 10th Duke of Northumberland: Chairmanship of the Agricultural and Medical Research Councils.","authors":"John Hedley-Whyte, Debra R Milamed","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 2","pages":"96-103"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes In Acute Kidney Injury Requiring Haemodialysis - A Retrospective Cohort Study. 需要血液透析的急性肾损伤的预后——一项回顾性队列研究。
Pub Date : 2025-09-01 Epub Date: 2025-09-30
S Chetcuti, A Masengu

Background: Acute kidney injury (AKI) requiring intermittent haemodialysis (AKI-IHD) is associated with significant morbidity and high mortality. There is limited data regarding clinical outcomes in individuals with AKI-IHD in Northern Ireland. The aim of this study was to explore clinical outcomes in a cohort of individuals with AKI-IHD, including rates of recovery to self-sustaining kidney function, mortality rates at 30 days and 2 years from start of haemodialysis, and to investigate potential predictors of these key outcomes.

Methods: The Acute Haemodialysis Unit in the Royal Victoria Hospital, Belfast, Northern Ireland, was established in 2011 to provide onsite inpatient intermittent haemodialysis (IHD) to individuals requiring this supportive treatment. A retrospective review of 188 incident IHD patients in the Royal Victoria Hospital from January 2018-December 2022 was undertaken. Demographic and clinical outcome information on 12th May 2023 was obtained from the nephrology electronic database eMed (Mediqal) and the Northern Ireland Electronic Care Record.

Results: 188 individuals commenced IHD for the first time as a consequence of life-threatening complications of AKI during the 5-year period (January 2018-December 2022).75% of these patients were not previously known to the nephrology service, (GROUP A, n=142, mean age 63 years, mean baseline serum creatinine 99 μmol/L) while 25% (GROUP B, n=46, mean age 67 years, mean baseline creatinine 278 μmol/L) had been attending a Nephrology Clinic for at least 12 months.A significant proportion of AKI developed during the inpatient admission rather than at initial presentation (GROUP A 47%, GROUP B 50%).92% of GROUP A recovered self-sustaining kidney function before discharge, compared to 59% of GROUP B. A lower baseline serum creatinine was the only predictor of kidney recovery in GROUP B, p value=0.02. No predictors for kidney recovery were identified in GROUP A.The diagnosis of either AKI and/or dialysis was documented in 80% of electronic discharge letters for patients in GROUP A but only 54% of letters for patients in GROUP B.The 30-day mortality (from IHD start) in GROUPA was 14% compared to 9% in GROUP B. Individuals with a diagnosis of heart failure were four times more likely to die before discharge (p value=0.02) and those aged ≥ 70 years twice as likely to die before discharge (p value=0.049). The two-year mortality rate in the two groups was similar (GROUP A 35% vs. GROUP B 37%) despite GROUP B being significantly older.

Conclusion: In this cohort of individuals with AKI-IHD, managed in the Royal Victoria Hospital, Belfast, the majority recovered self-sustaining kidney function.The mortality rates at 30 days were lower than reported in the literature and may be due to careful patient selection. The poorer outcomes associated with AKI-IHD support and a concomitant diagnosis of heart failure or age

背景:急性肾损伤(AKI)需要间歇性血液透析(AKI- ihd)与显著的发病率和高死亡率相关。关于北爱尔兰AKI-IHD患者的临床结果的数据有限。本研究的目的是探讨AKI-IHD患者队列的临床结果,包括自我维持肾功能的恢复率、血液透析开始后30天和2年的死亡率,并探讨这些关键结果的潜在预测因素。方法:北爱尔兰贝尔法斯特皇家维多利亚医院急性血液透析科成立于2011年,为需要这种支持性治疗的患者提供现场住院间歇性血液透析(IHD)。回顾性分析了2018年1月至2022年12月在皇家维多利亚医院发生的188例IHD患者。2023年5月12日的人口统计和临床结果信息来自肾脏病电子数据库eMed (Mediqal)和北爱尔兰电子护理记录。结果:在5年期间(2018年1月至2022年12月),188人因AKI危及生命的并发症首次开始IHD。其中75%的患者以前没有肾科服务,(A组,n=142,平均年龄63岁,平均基线血清肌酐99 μmol/L),而25% (B组,n=46,平均年龄67岁,平均基线肌酐278 μmol/L)已经在肾科诊所就诊至少12个月。在住院期间发生AKI的比例很大,而不是在初次就诊时(A组47%,B组50%)。92%的A组患者在出院前恢复了自维持肾功能,而B组为59%。较低的基线血清肌酐是B组患者肾脏恢复的唯一预测指标,p值=0.02。没有确定预测肾功能恢复组诊断AKI的和/或透析是记录在电子放电字母病人集团80%的信件的但只有54%的病人在b组30天死亡率(IHD开始)GROUPA 14%到9%在b组患者诊断为心力衰竭死亡的可能性是其他人的4倍放电前(p值= 0.02)和≥70岁之前死的几率要高出一倍放电(p值= 0.049)。两组的两年死亡率相似(A组35%对B组37%),尽管B组明显更老。结论:在贝尔法斯特皇家维多利亚医院管理的AKI-IHD患者队列中,大多数患者恢复了自我维持的肾功能。30天的死亡率低于文献报道,可能是由于谨慎的患者选择。与AKI-IHD支持相关的较差结果以及伴随心力衰竭或年龄≥70岁(或两者兼而有之)的诊断有助于指导临床和患者的期望和决策。
{"title":"Outcomes In Acute Kidney Injury Requiring Haemodialysis - A Retrospective Cohort Study.","authors":"S Chetcuti, A Masengu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) requiring intermittent haemodialysis (AKI-IHD) is associated with significant morbidity and high mortality. There is limited data regarding clinical outcomes in individuals with AKI-IHD in Northern Ireland. The aim of this study was to explore clinical outcomes in a cohort of individuals with AKI-IHD, including rates of recovery to self-sustaining kidney function, mortality rates at 30 days and 2 years from start of haemodialysis, and to investigate potential predictors of these key outcomes.</p><p><strong>Methods: </strong>The Acute Haemodialysis Unit in the Royal Victoria Hospital, Belfast, Northern Ireland, was established in 2011 to provide onsite inpatient intermittent haemodialysis (IHD) to individuals requiring this supportive treatment. A retrospective review of 188 incident IHD patients in the Royal Victoria Hospital from January 2018-December 2022 was undertaken. Demographic and clinical outcome information on 12th May 2023 was obtained from the nephrology electronic database eMed (Mediqal) and the Northern Ireland Electronic Care Record.</p><p><strong>Results: </strong>188 individuals commenced IHD for the first time as a consequence of life-threatening complications of AKI during the 5-year period (January 2018-December 2022).75% of these patients were not previously known to the nephrology service, (GROUP A, n=142, mean age 63 years, mean baseline serum creatinine 99 μmol/L) while 25% (GROUP B, n=46, mean age 67 years, mean baseline creatinine 278 μmol/L) had been attending a Nephrology Clinic for at least 12 months.A significant proportion of AKI developed during the inpatient admission rather than at initial presentation (GROUP A 47%, GROUP B 50%).92% of GROUP A recovered self-sustaining kidney function before discharge, compared to 59% of GROUP B. A lower baseline serum creatinine was the only predictor of kidney recovery in GROUP B, p value=0.02. No predictors for kidney recovery were identified in GROUP A.The diagnosis of either AKI and/or dialysis was documented in 80% of electronic discharge letters for patients in GROUP A but only 54% of letters for patients in GROUP B.The 30-day mortality (from IHD start) in GROUPA was 14% compared to 9% in GROUP B. Individuals with a diagnosis of heart failure were four times more likely to die before discharge (p value=0.02) and those aged ≥ 70 years twice as likely to die before discharge (p value=0.049). The two-year mortality rate in the two groups was similar (GROUP A 35% vs. GROUP B 37%) despite GROUP B being significantly older.</p><p><strong>Conclusion: </strong>In this cohort of individuals with AKI-IHD, managed in the Royal Victoria Hospital, Belfast, the majority recovered self-sustaining kidney function.The mortality rates at 30 days were lower than reported in the literature and may be due to careful patient selection. The poorer outcomes associated with AKI-IHD support and a concomitant diagnosis of heart failure or age","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 2","pages":"77-82"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-directed learning and clinical decision support. 自主学习和临床决策支持。
Pub Date : 2025-09-01 Epub Date: 2025-09-30
Kieran Walsh, Lynsey Morton
{"title":"Self-directed learning and clinical decision support.","authors":"Kieran Walsh, Lynsey Morton","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 2","pages":"94-95"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceptions of Obesity and Bariatric Surgery Among Newly Qualified Doctors: A UK-based Multi-Hospital Survey Study. 新合格医生对肥胖和减肥手术的看法:一项英国多医院调查研究
Pub Date : 2025-09-01 Epub Date: 2025-09-30
Christopher R Smith, Robin Pontonnier, Theodore Patel, Ravikrishna Mamidanna, Michail Chatzikonstantinou

Background: Obesity is a major public health challenge, yet formal education on bariatric and metabolic surgery (BMS) remains limited in undergraduate and early postgraduate medical training. Foundation Year 1 (FY1) doctors are often responsible for managing post-operative bariatric patients, but their confidence and preparedness in this area are unclear. This study aimed to assess FY1 doctors' confidence, knowledge, and perceptions of BMS, identifying educational gaps to guide future training.

Methods: A cross-sectional survey was distributed to FY1 doctors across seven hospitals in South-East London (August- December 2024). The questionnaire assessed demographics, confidence in managing BMS patients, prior training knowledge, and perceptions of obesity and BMS.

Results: Seventy-seven FY1 doctors participated. The majority (77.9%, n=60) had no formal BMS training, and fewer than half (42.9%, n=33) had clinical exposure to BMS patients. Only 20.8% (n=16) felt comfortable managing these patients, with confidence levels higher among those with prior clinical exposure but without statistical significance (p = 0.0682). Misconceptions were present, with 41.6% (n=32) believing obesity is self-inflicted and 7.8% (n=6) viewing BMS as cosmetic. A majority (84.4%, n=65) supported integrating BMS education into medical training.

Conclusion: FY1 doctors demonstrated low confidence in managing bariatric patients, possibly due to limited training and exposure. Findings highlight the need for structured BMS education, focusing on peri-operative care rather than procedural details, to better equip future doctors in managing obesity and post-bariatric surgery patients.

背景:肥胖是一个主要的公共卫生挑战,然而在本科和早期研究生医学培训中,关于减肥和代谢手术(BMS)的正规教育仍然有限。基础一年级(FY1)的医生通常负责管理术后肥胖患者,但他们在这方面的信心和准备尚不清楚。本研究旨在评估FY1医生对BMS的信心、知识和认知,确定教育差距,以指导未来的培训。方法:对伦敦东南部7家医院的FY1医生进行横断面调查(2024年8月至12月)。问卷评估了人口统计、管理BMS患者的信心、先前的培训知识以及对肥胖和BMS的认知。结果:77名FY1医生参与。大多数(77.9%,n=60)没有接受过正式的BMS培训,不到一半(42.9%,n=33)有临床接触BMS患者的经历。只有20.8% (n=16)的人对管理这些患者感到舒适,在有临床暴露史的患者中信心水平更高,但没有统计学意义(p = 0.0682)。存在误解,41.6% (n=32)的人认为肥胖是自己造成的,7.8% (n=6)的人认为BMS是一种美容。大多数(84.4%,n=65)支持将BMS教育纳入医学培训。结论:FY1医生在管理肥胖患者方面表现出较低的信心,可能是由于有限的培训和暴露。研究结果强调有必要进行结构化的BMS教育,重点关注围手术期护理,而不是手术细节,以更好地装备未来的医生管理肥胖和减肥手术后患者。
{"title":"Perceptions of Obesity and Bariatric Surgery Among Newly Qualified Doctors: A UK-based Multi-Hospital Survey Study.","authors":"Christopher R Smith, Robin Pontonnier, Theodore Patel, Ravikrishna Mamidanna, Michail Chatzikonstantinou","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Obesity is a major public health challenge, yet formal education on bariatric and metabolic surgery (BMS) remains limited in undergraduate and early postgraduate medical training. Foundation Year 1 (FY1) doctors are often responsible for managing post-operative bariatric patients, but their confidence and preparedness in this area are unclear. This study aimed to assess FY1 doctors' confidence, knowledge, and perceptions of BMS, identifying educational gaps to guide future training.</p><p><strong>Methods: </strong>A cross-sectional survey was distributed to FY1 doctors across seven hospitals in South-East London (August- December 2024). The questionnaire assessed demographics, confidence in managing BMS patients, prior training knowledge, and perceptions of obesity and BMS.</p><p><strong>Results: </strong>Seventy-seven FY1 doctors participated. The majority (77.9%, n=60) had no formal BMS training, and fewer than half (42.9%, n=33) had clinical exposure to BMS patients. Only 20.8% (n=16) felt comfortable managing these patients, with confidence levels higher among those with prior clinical exposure but without statistical significance (p = 0.0682). Misconceptions were present, with 41.6% (n=32) believing obesity is self-inflicted and 7.8% (n=6) viewing BMS as cosmetic. A majority (84.4%, n=65) supported integrating BMS education into medical training.</p><p><strong>Conclusion: </strong>FY1 doctors demonstrated low confidence in managing bariatric patients, possibly due to limited training and exposure. Findings highlight the need for structured BMS education, focusing on peri-operative care rather than procedural details, to better equip future doctors in managing obesity and post-bariatric surgery patients.</p>","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 2","pages":"89-93"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12476118/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145188172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thoughts on the Passing of Dr John Geddes. 对约翰·格迪斯博士逝世的思考。
Pub Date : 2025-04-01 Epub Date: 2025-04-30
S W Webb, J A Purvis
{"title":"Thoughts on the Passing of Dr John Geddes.","authors":"S W Webb, J A Purvis","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 1","pages":"40-41"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144056225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curiositas - Gastrointestinal Celebritas. 胃饱和度名人。
Pub Date : 2025-04-01 Epub Date: 2025-04-30
{"title":"Curiositas - Gastrointestinal Celebritas.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 1","pages":"53-54"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144036473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First steps down the slippery slope?: An analysis of the slippery-slope argument and its application to the question of assisted suicide. 走下坡路的第一步?滑坡论点的分析及其在协助自杀问题上的应用。
Pub Date : 2025-04-01 Epub Date: 2025-04-30
Michael Trimble

On 29 November 2024, the House of Commons voted in favour of legalising assisted suicide. The aim of the Bill is to "allow adults who are terminally ill, subject to safeguards and protections, to request and be provided with assistance to end their own life." At the time of writing, the Bill is under consideration at the Committee stage. This paper considers the implications of the bill and the appropriateness of using the "slippery slope" argument in its critique. It may be seen that when considering the practice of assisted suicide in jurisdictions where it has been legalised, the empirical form of the argument is shown to be valid. However, the logical form of the argument is less relevant as, once the principle is conceded, there are no further significant barriers and the slope is, in fact, a cliff edge. History shows that the proposed safeguards are unlikely to be robust or sufficient to withstand challenge.

2024年11月29日,下议院投票赞成协助自杀合法化。该法案的目的是“允许身患绝症的成年人在受到保障和保护的情况下,请求并获得帮助以结束自己的生命。”在撰写本报告时,条例草案正处于委员会审议阶段。本文考虑了该法案的含义以及在其批评中使用“滑坡”论点的适当性。可以看出,当考虑协助自杀在其合法化的司法管辖区的实践时,论证的经验形式被证明是有效的。然而,论证的逻辑形式是不太相关的,因为一旦原则被承认,就没有进一步的重大障碍,斜坡实际上是一个悬崖边缘。历史表明,拟议的保障措施不太可能强大或足以承受挑战。
{"title":"First steps down the slippery slope?: An analysis of the slippery-slope argument and its application to the question of assisted suicide.","authors":"Michael Trimble","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>On 29 November 2024, the House of Commons voted in favour of legalising assisted suicide. The aim of the Bill is to \"allow adults who are terminally ill, subject to safeguards and protections, to request and be provided with assistance to end their own life.\" At the time of writing, the Bill is under consideration at the Committee stage. This paper considers the implications of the bill and the appropriateness of using the \"slippery slope\" argument in its critique. It may be seen that when considering the practice of assisted suicide in jurisdictions where it has been legalised, the empirical form of the argument is shown to be valid. However, the logical form of the argument is less relevant as, once the principle is conceded, there are no further significant barriers and the slope is, in fact, a cliff edge. History shows that the proposed safeguards are unlikely to be robust or sufficient to withstand challenge.</p>","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 1","pages":"42-46"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The New Absence. 新的缺席。
Pub Date : 2025-04-01 Epub Date: 2025-04-30
David J Armstrong
{"title":"The New Absence.","authors":"David J Armstrong","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"94 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Ulster medical journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1